etoposide has been researched along with Retinal Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Das, A; Das, N; Ranjan, R; Shah, PK | 1 |
| Hirami, Y; Kawagoe, N; Mandai, M; Mio, T; Mishima, M; Sakuma, K; Takahashi, M; Yoshimura, N | 1 |
| Chan, HS; Dimaras, H; Gallie, BL; Halliday, W; Héon, E; Khetan, V | 1 |
| Damasco, VC; Dire, DJ | 1 |
| Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH | 1 |
| Goldstein, DA; Tessler, HH | 1 |
| Kashiwabara, K; Kishi, K; Kobayashi, K; Matsuoka, T; Nakamura, H; Sarashina, G; Yagyu, H | 1 |
7 other study(ies) available for etoposide and Retinal Diseases
| Article | Year |
|---|---|
Bilateral macular ischemia following oral etoposide.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ischemia; Macula Lutea; Retinal Diseases | 2020 |
[Case of cancer-associated retinopathy in which immediate treatment succeeded].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Methylprednisolone; Paraneoplastic Syndromes; Prednisolone; Pulse Therapy, Drug; Retinal Diseases; Treatment Outcome | 2008 |
Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calcinosis; Carboplatin; Child, Preschool; Cyclosporine; Etoposide; Eye Enucleation; Humans; Male; Retinal Diseases; Retinal Neoplasms; Retinoblastoma; Vincristine | 2009 |
A child with leukocoria.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Diagnosis, Differential; Emergencies; Etoposide; Eye Abnormalities; Eye Enucleation; Eye Neoplasms; Eye Pain; Humans; Male; Pupil Disorders; Remission Induction; Retinal Diseases; Retinoblastoma; Vincristine | 2011 |
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery | 2007 |
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases | 2007 |
Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
Topics: Adrenal Cortex Hormones; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Calcium-Binding Proteins; Carboplatin; Carcinoma, Small Cell; Etoposide; Eye Proteins; Female; Hippocalcin; Humans; Immunosuppressive Agents; Lipoproteins; Lung Neoplasms; Nerve Tissue Proteins; Paraneoplastic Syndromes; Recoverin; Retinal Diseases; Vision, Low; Visual Acuity | 1999 |